title: Emerging drugs for complicated skin and skin-structure infections.
abstract: IMPORTANCE OF THE FILED: With the worldwide surge of MRSA, skin and skin-structure infection (SSTI) treatment has become a challenge for physicians. Cultures and antibiotic susceptibility tests for SSTIs are the rule due to the implication in morbidity and mortality rates associated with MRSA infections. The need for new antibiotics is evident and the effort to decrease antibiotic resistance is a world priority.
  
  
  METHODS
  This manuscript accesses the actual treatments and the developing of antibiotics for MRSA SSTIs.
  
  
  RESULTS
  This is a review of the data on the available and emerging treatments for MRSA SSTIs.
  
  
  CONCLUSIONS
  There is an unmet medical need for new antibiotics in the new millennium. As physicians, we must assure all appropriate procedures are completed in order to reduce the bacterial resistance, especially for MRSA.
authors.affiliation: Center for Clinical Studies, 6655 Travis Suite 120, Houston, TX 77030, USA. nmendoza@ccstexas.com
authors.forename: Natalia
authors.initials: N
authors.lastname: Mendoza
authors.forename: Stephen K
authors.initials: SK
authors.lastname: Tyring
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D016106:Methicillin Resistance; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D018461:Soft Tissue Infections / Q000188:drug therapy* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013207:Staphylococcal Skin Infections / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents